A Single-arm, Open-label Study to Evaluate a Procedure for Intra-articular (IA) Injection of FX006 in Patients With Osteoarthritis (OA) of the Hip
Latest Information Update: 08 Jan 2024
At a glance
- Drugs Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Flexion Therapeutics; Pacira BioSciences
Most Recent Events
- 14 Feb 2020 Status changed from active, no longer recruiting to completed.
- 08 Nov 2019 Planned End Date changed from 30 Oct 2019 to 6 Dec 2019.
- 08 Nov 2019 Status changed from recruiting to active, no longer recruiting.